Bio Pharma Dive
DECEMBER 5, 2022
After a private equity takeover unraveled this summer, the women’s health company is selling its drug portfolio to Mayne Pharma in a $153 million deal.
Pharmaceutical Technology
DECEMBER 5, 2022
Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub. According to the latest deal, the University of Queensland (UQ) and Griffith University will serve as foundational partners.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 5, 2022
The positive results could help Novartis secure approval for earlier use of the radiopharmaceutical drug Pluvicto, potentially broadening the number of eligible patients by several times the current market.
Pharmaceutical Technology
DECEMBER 5, 2022
Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In 2022, a surge in the pipeline has led to cannabinoid receptors becoming the most popular target in preclinical development. Despite this, the medical use of cannabinoid drugs is heavily restricted, including being banned in 137 countries, according to the United Nations.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Bio Pharma Dive
DECEMBER 5, 2022
Maria-Cruz Morillo, global therapeutic operations lead for rare diseases at Allucent, discusses the unique challenges of rare disease drug development and how the right expertise can help.
Pharmaceutical Technology
DECEMBER 5, 2022
On September 19, Lupkynis (voclosporin), a therapy for lupus nephritis (LN), received European Commission (EC) approval, becoming the second therapy approved in the EU for the treatment of LN after Benlysta (belimumab) from GlaxoSmithKline. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has also since granted the Great Britain marketing authorisation of Lupkynis to treat adults with active LN.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
DECEMBER 5, 2022
UK-based company AstraZeneca’s IT hiring declined 3.1% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 2.15% in November 2022 when compared with October 2022. IT jobs claimed an 8.36% share in the company’s total hiring activity in November 2022, and recorded a 0.26% decline over the last three-month average share.
Bio Pharma Dive
DECEMBER 5, 2022
When Talisa Puentes-Ortega got the chance to advance her career by going back to school, Regis provided more than an environmental biology degree — it was the foundation of a community that continues to support her.
Pharmaceutical Technology
DECEMBER 5, 2022
Luxembourg-based company Eurofins Scientific’s IT hiring declined 10.6% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 10.33% in November 2022 when compared with October 2022. IT jobs claimed a 5.73% share in the company’s total hiring activity in November 2022, and recorded a 0.26% growth over the last three-month average share.
Bio Pharma Dive
DECEMBER 5, 2022
The updated study results add to evidence that such therapies may help treat B-cell lymphomas. But it’s still unclear how long their effects could last.
Advertisement
There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.
Pharmaceutical Technology
DECEMBER 5, 2022
US-based company MerckInc’s IT hiring declined 8.6% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 13.09% in November 2022 when compared with October 2022. IT jobs claimed a 4.99% share in the company’s total hiring activity in November 2022, and recorded a 0.4% decline over the last three-month average share.
Bio Pharma Dive
DECEMBER 5, 2022
The two remaining suitors said they would make cash bids if they move forward with offers, for which they must declare “firm intent” by Jan. 10 under Irish takeover rules.
Pharmaceutical Technology
DECEMBER 5, 2022
US-based company Parexel International’s IT hiring declined 3.0% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 9.68% in November 2022 when compared with October 2022. IT jobs claimed a 13.42% share in the company’s total hiring activity in November 2022, and recorded a 1.54% growth over the last three-month average share.
Medical Xpress
DECEMBER 5, 2022
Despite years of research, discussions and advocacy in relation to nurturing children's development through healthy eating and active living, there's been very little in the way of progress—sugary drinks are still advertised prolifically, there's hidden salt and sugar in foods, and most kids spend more time in front of screens rather than outside.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmaceutical Technology
DECEMBER 5, 2022
US-based company Syneos Health’s IT hiring declined 4.2% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 11.94% in November 2022 when compared with October 2022. IT jobs claimed a 10.55% share in the company’s total hiring activity in November 2022, and recorded a 1.46% growth over the last three-month average share.
Medical Xpress
DECEMBER 5, 2022
Up to 78% of walkers would take a more challenging route featuring obstacles such as balancing beams, steppingstones and high steps, research has found. The findings suggest that providing 'Active Landscape' routes in urban areas could help tackle an "inactivity pandemic" and improve health outcomes.
Pharmaceutical Technology
DECEMBER 5, 2022
Incyte has signed a partnership and licence agreement with CMS subsidiary CMS Aesthetics to develop and market ruxolitinib cream to treat autoimmune and inflammatory dermatologic ailments in Greater China and some Southeast Asian countries. According to the deal, Incyte is entitled to receive an upfront payment from CMS, which will also make further potential payments on meeting development, regulatory and commercial milestones.
pharmaphorum
DECEMBER 5, 2022
A digital health assistant that can help people at risk of becoming dependent on alcohol has been launched in Belize, its first country, by the World Health Organisation (WHO) and Pan-American Health Organisation (PAHO). The artificial intelligence-powered assistant – called Pahola and available as a free online chat-based site – is designed to provide information and guidance to help people reduce their alcohol consumption, helping to prevent more than 200 health conditions linked to excessive
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
DECEMBER 5, 2022
Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. According to the definitive agreements, Mayne will obtain an exclusive licence for commercialising TherapeuticsMD’s Imvexxy and Bijuva, as well as its prescription prenatal vitamin products marketed under the brands namely BocaGreenMD and vitaMedMD.
NPR Health - Shots
DECEMBER 5, 2022
A new documentary All The Beauty and the Bloodshed tells the story of Nan Goldin, a photographer and activist who survived opioid addiction — then challenged members of the Sackler family.
Pharmaceutical Technology
DECEMBER 5, 2022
Spain’s pharma industry registered a 9.1% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 15.22% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 10.51% share in November 2022, recording an increase of 1.01% over the last three-month average share.
STAT News
DECEMBER 5, 2022
Next year, UnitedHealth Group — one of the largest health care companies on the planet — expects to make a lot more money in a relatively simple way: by funneling more of the insurance premiums it collects from workers and taxpayers toward itself. That’s possible because UnitedHealth, known for its sprawling insurance presence, has pivoted to become one of the largest providers of outpatient care by acquiring numerous physician practices, surgery centers, urgent care facilit
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Technology
DECEMBER 5, 2022
The UK’s pharma industry registered a 25.9% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 36.99% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.37% share in November 2022, recording a decrease of 1.1% over the last three-month average share.
NPR Health - Shots
DECEMBER 5, 2022
The disease, which predominantly affects patients of color, can damage the body in ways that can make it difficult to have a child. But patients don't always have access to fertility care.
Pharmaceutical Technology
DECEMBER 5, 2022
Switzerland’s pharma industry registered a 25.4% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 19.13% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 2.94% share in November 2022, recording a decrease of 0.13% over the last three-month average share.
BioSpace
DECEMBER 5, 2022
The worldwide market for therapeutics designed specifically for conditions and diseases that affect mainly women is expected to exceed $65 billion by 2027. BioSpace looks at three femtech leaders.
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
Pharmaceutical Technology
DECEMBER 5, 2022
The US’s pharma industry registered a 15.6% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 11.32% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.57% share in November 2022, recording a decrease of 0.17% over the last three-month average share.
Medical Xpress
DECEMBER 5, 2022
The cancer therapy known as CAR-T has revolutionized treatment of some blood cancers since it was introduced in 2017. The therapy uses genetically altered immune cells to home in on cancer cells and destroy them.
STAT News
DECEMBER 5, 2022
Congress is considering two measures that modernize tools the Food and Drug Administration uses to oversee two areas of its vast portfolio: diagnostic tests and cosmetics. While the stakes are different for each of these industries, the basic premise driving these measures is the same. The FDA is currently working from an outdated regulatory playbook that has left gaps in its oversight of safety and effectiveness and makes it more difficult to introduce new innovations.
Medical Xpress
DECEMBER 5, 2022
Baseball may be America's favorite pastime, but in rankings of the most popular hobbies, reading is more consistently ranked highly. It's not hard to see why: reading is simultaneously engaging and relaxing, and it's fun to do alone and with friends.
Speaker: Steve Goldstein, Sales Leader
Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g
Expert insights. Personalized for you.
329 
Let's personalize your content